CTRI/2024/04/065764尚未招募3 期
A Randomised control trial of Efficacy of early IV oxytocin infusion at the time of Abdominal skin incision in decreasing blood loss in emergency primary caesarean section
DrBHACKIYA1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年5月1日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Evaluate The Efficacy Of Early Iv Oxytocin Infusion In Primary Caeserean Section In Reduction Of Intraoperative And Post Operative Blood Loss And In Reduction Of Usage Additional Uterotonics
研究概览
简要总结
Aim of this randomised control trial is to evaluate the efficacy of early iv oxytocin infusion that is at the time of abdominal skin incision in emergency primary c section which reduces intraop and postoperative blood loss and additional uterotonic usage and blood transfusion and in reducing the maternal mortality rate by postpartum haemorrhage
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 19.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Primi Singleton Pregnancy with 37 completed weeks of gestation taken up for Emergency primary caeserean section 2.Multiparous women with previous normal vaginal delivery / previous instrumental deliveries with 37 completed weeks of gestation who are taken up for Emergency Primary caesarean section.
排除标准
- •Obesity ,Heart disease, Gestational Hypertension, Gestational Diabetes mellitus on Insulin, Previous LSCS ,Previous Myomectomy ,Previous Laparotomy.
结局指标
主要结局
Evaluate The Efficacy Of Early Iv Oxytocin Infusion In Primary Caeserean Section In Reduction Of Intraoperative And Post Operative Blood Loss And In Reduction Of Usage Additional Uterotonics
时间窗: 5 months
Â
时间窗: 5 months
次要结局
- In This Study Intraoperative And Post Operative Haemorrhage Can Be Reduced And Hence Maternal Mortality Due To Pph Can Be Reduced(2 years)
研究者
BHACKIYA
Government Thanjavur Medical college and hospital
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A study to test whether BI 706321 combined with ustekinumab helps people with Crohn's Disease2024-512756-38-00Boehringer Ingelheim International GmbH27
招募中
3 期
A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) induction and lenalidomide maintenance in patients with newly diagnosed multiple myeloma (GMMG-HD7)Multiple Myeloma2024-513464-26-00Universitaetsklinikum Heidelberg AöR662
尚未招募
3 期
A clinical trial to evaluate safety of early de-escalation of antibiotics in children with cancer based on procalcitonin levelsCTRI/2025/10/095526VARDHAMAN MAHAVIR MEDICAL COLLEGE SAFDARJUNG HOSPITAL NEW DELHI60
招募中
1/2 期
Comparison of Early Breathing Tube Placement in the Windpipe versus Conventional Timing of Breathing Tube Placement in Children with Severe Life-Threatening Infection and Poor Blood Flow to Human Body Organs.CTRI/2025/09/094266Dr Himmat Ram Siyag104
尚未招募
2 期
Effect of Ayurvedic medicine in Hypothyroidism.CTRI/2025/02/081276Shraddha Dattatray Satre80